エクト寄生虫 - 過小評価されている領域
Jörg Heukelbach1, Hermann Feldmeier
1Mandacaru Foundation and Department of Community Medicine, Federal University of Ceará State, Fortaleza, Brazil.
Lancet (London, England)
|March 23, 2004
まとめ
頭 lice (Pediculus humanus capitis) と scabies (Sarcoptes scabiei) の殺虫剤耐性は,世界的な問題として増大しています. 耐性パターンを理解し,イヴァルメクチンなどの経口療法を含む効果的な制御戦略を開発するために,新しい研究が必要です.
科学分野:
- 皮膚科 皮膚科について
- 寄生虫学とは,寄生虫学である.
- 公衆衛生は公衆衛生である.
背景:
- ペディキュロシスやなど,エクトパラシト菌は,世界中で著しい罹病率を引き起こします.
- 頭 lice (Pediculus humanus capitis) と scabies mites (Sarcoptes scabiei) の一般的な殺虫剤に対する抵抗性の増大は,主要な治療課題となっています.
- これらの耐性菌株の管理に関する既存の科学的知識は限られており,証拠に基づいた制御措置が不足しています.
研究 の 目的:
- P. humanus capitis と S. scabiei. の殺虫剤耐性に関する臨床疫学研究の緊急の必要性を強調する.
- 特に資源が乏しい環境では,口服用イヴァルメクチンなどの代替治療方法を検討する.
- 医療介入と公衆衛生のアプローチを組み合わせた統合された制御戦略の必要性を強調する.
主な方法:
- P. humanus capitisとS. scabiei.の昆虫剤耐性パターンに関する既存の文献のレビュー
- 異なる地理的地域 (オーストラリア,米国,エクアドルなど) で報告された耐性病例の分析.
- 潜在的な代替治療法と統合された制御戦略の議論.
主要な成果:
- マラチオン,ペルメトリン,ピレスラムに対するP. humanus capitisの広範囲にわたる殺虫剤耐性の文書化された症例.
- 異なる地理的位置で観察された可変性耐性パターンは,複雑な疫学的状況を示しています.
- 局所療法に対する潜在的な代替手段として口服用イヴァルメクチンの特定,特にポリパラジティズムのある地域で.
結論:
- 耐性頭 lice と scabies の地理的広がりと数値的な増加が予想されています.
- 耐性菌株の出現と拡散を促す要因を理解するために,緊急に研究が必要です.
- 効果的な予防には,地域の疫学,新しい治療法,環境衛生,健康教育,文化的に適切な介入に関する理解を深めることが必要である.
関連する概念動画
Diversity of Protists I
Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
Microbial Interactions: Parasitism
Parasitism is a form of microbial interaction in which parasitic microbes exploit a host organism for nutrients and shelter, often at the host's expense. Unlike mutualistic relationships, where both organisms benefit, parasitism benefits only the parasite and harms the host.Classification of ParasitesMicrobial parasites are broadly classified based on their location relative to the host.Ectoparasites remain on the host’s surface, such as the skin or outer tissues, drawing nutrients...
Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...


